Β-Hydroxythiofentanyl
Synthetic opioid analgesic
Β-Hydroxythiofentanyl is a potent opioid analgesic that is structurally related to fentanyl. It is a member of the thiofentanyl family, which are synthetic opioids known for their high potency and rapid onset of action. Β-Hydroxythiofentanyl is primarily used in research settings and is not approved for medical use in humans.
Chemical Structure and Properties[edit]

Β-Hydroxythiofentanyl is chemically classified as an anilidopiperidine derivative. Its structure includes a piperidine ring, which is a common feature in many opioid compounds. The presence of a thiophene ring distinguishes it from other fentanyl analogs, contributing to its unique pharmacological properties.
The compound is characterized by the addition of a hydroxyl group, which may influence its interaction with the opioid receptors in the central nervous system. This modification can affect the drug's potency, duration of action, and side effect profile.
Pharmacology[edit]
Β-Hydroxythiofentanyl acts as a full agonist at the mu-opioid receptor, similar to other opioids in the fentanyl family. This receptor interaction is responsible for its analgesic effects, as well as its potential for respiratory depression, euphoria, and physical dependence.
The potency of Β-Hydroxythiofentanyl is significantly higher than that of morphine, making it a subject of interest in the study of opioid receptor binding and analgesic efficacy. However, its high potency also raises concerns about the risk of overdose and opioid toxicity.
Legal Status[edit]
Due to its structural similarity to fentanyl and its potential for abuse, Β-Hydroxythiofentanyl is classified as a Schedule I controlled substance in many jurisdictions. This classification indicates that it is considered to have a high potential for abuse and no accepted medical use.
Synthesis and Research[edit]
The synthesis of Β-Hydroxythiofentanyl involves the modification of the fentanyl structure to include a thiophene ring and a hydroxyl group. This process requires advanced knowledge of organic chemistry and access to specialized laboratory equipment.
Research on Β-Hydroxythiofentanyl is primarily focused on understanding its pharmacological properties and potential applications in pain management. However, due to its legal status, research is limited and highly regulated.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian